Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD/PK of Subcutaneous Depo-Provera
NCT02456584Phase 1Completed
- Sponsor
- FHI 360
- Start
- Sep 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, open-label trial of medroxyprogesterone acetate in contraception (3 arms), sponsored by FHI 360. Primary endpoint: Measure of time to ovulation up to 18 months. Started Sep 2015; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02456584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456584.